Mainland China
Innovent Announces Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) Combined with Bevacizumab in Advanced Colorectal Cancer at the 2024 ESMO Congress
SAN FRANCISCO and SUZHOU, China, Sept. 18, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metaboli...
2024-09-18 08:00
2061
Innovent Delivers Oral Presentations on Clinical Data of IBI354 (HER2 Monoclonal Antibody-Camptothecin Derivative Conjugate) in Advanced Ovarian Cancer, Breast Cancer and Other Solid Tumors at the 2024 ESMO Congress
SAN FRANCISCO and SUZHOU, China, Sept. 18, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabol...
2024-09-18 08:00
2123
it.com Domains Continues to Grow, Announcing Innovative Domain Solutions in APAC via Japan's #1 Registrar, GMO
TOKYO, Sept. 17, 2024 /PRNewswire/ -- A provider of innovative domains, it.com Domains, is excited to announce the availability of its domains through GMO Internet Group, a leading domain registrar with the #1 market share inJapan[1]. This cooperation brings the it com domain extension to theAsia...
2024-09-17 23:06
2391
Breakthrough in the electrification of commercial vehicles: CATL Unveils Revolutionary TECTRANS Battery System
HANOVER, Germany, Sept. 17, 2024 /PRNewswire/ -- At IAA Transportation 2024,
Contemporary Amperex Technology Co., Limited (CATL), the global leader in new
energy technology innovations launched its groundbreaking TECTRANS battery
system, revolutionizing the commercial transportation sector.
2024-09-17 23:05
2257
Ascletis Enters the Obesity Drug Space with Announcement of Two Ongoing U.S. Phase I Clinical Trials Utilizing Its Small Molecule GLP-1R Agonist ASC30 for Both Once-Monthly Subcutaneous Injection and Once-Daily Oral Tablet for the Treatment of Obesity
- ASC30 is the first and only small molecule GLP-1 receptor (GLP-1R) agonist that can be dosed once-monthly subcutaneously and once-daily orally to treat obesity - ASC30 is two- to threefold more potent, in vitro, than orforglipron and stimulated significantly greater insulin secretion when comp...
2024-09-17 18:25
2156
The Spectacular Premiere of Jiangsu's Original Ethnic Dance Drama A Dream of Red Mansions in Singapore
SINGAPORE, Sept. 17, 2024 /PRNewswire/ -- With translucent white light illuminating the stage and silk curtains drawn low, the twelve heroines of A Dream of Red Mansions gracefully swayed their way forward, leading the audience into a shared dream. As the performance concluded, actors took multip...
2024-09-17 14:29
1517
Steelhead LNG Initiates Patent Infringement Litigation Against Cedar LNG and Samsung Heavy Industries in Korea
VANCOUVER, BC, Sept. 16, 2024 /PRNewswire/ -- Steelhead LNG, a Vancouver-based developer in the liquefied natural gas (LNG) industry, today announced the commencement of patent infringement proceedings against [Cedar LNG] and Samsung Heavy Industries Co., Ltd. ("Samsung Heavy") in the Republic of...
2024-09-17 06:00
2042
State Grid Heze Power Supply Company: high-quality power service boost autumn peach fragrance
HEZE, China, Sept. 16, 2024 /PRNewswire/ -- On September 5, in the Yellow River beach district of Shandong Province Heze Kuigudui Village, Juancheng County rich farmers fruit planting base, the staff is busy picking in the peach orchard, not for a while, the car has been full of baskets, then pul...
2024-09-16 22:01
2020
Huawei Teases New Pro-level MatePad, with Groundbreaking Display and Updated GoPaint App
BARCELONA, Spain, Sept. 16, 2024 /PRNewswire/ -- Huawei is said to be launching a new MatePad Pro Series tablet during its launch inBarcelona this September. An intersection of power-packed innovation and artistic inspiration, the tablet is said to be introducing a groundbreaking upgrade of its d...
2024-09-16 20:26
2524
From Maritime Silk Road Hub to "Trade Window": Guangdong's Continuous Push for Opening Up
GUANGDONG, China, Sept. 16, 2024 /PRNewswire/ -- Since the Tang Dynasty
(618-907), Guangzhou inGuangdong Province has been a prominent port where
Sino-foreign trade flourished, attracting numerous foreign merchants who
traveled here along the Maritime Silk Road.
2024-09-16 17:15
2228
Alphamab Oncology Presented the Latest Clinical Data from Two Studies on Anti-HER2 Bispecific ADC JSKN003 at the ESMO Congress 2024
SUZHOU, China, Sept. 16, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the latest clinical data from two studies on anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 were presented at the 2024 European Society for Medical Oncology Congress (ESMO Congress 202...
2024-09-16 13:03
1957
Temple Mall Presents "Blue-and-White Porcelain Impressions" Art Experience
Collaborating with Local Artist Angel Hui to Explore the Beauty of a Millennia-old Cultural Treasure * Temple Mall presents a themed event and exhibition celebrating blue-and-white porcelain, inviting the public to explore and appreciate the rich heritage of this millennia-old cultural treasur...
2024-09-16 09:00
2697
Xinhua Silk Road: Jiangcun Academy, a new highland for rural revitalization and social science research under construction in E. China's Suzhou
BEIJING, Sept. 14, 2024 /PRNewswire/ -- The educational project Jiangcun
Academy aimed at inheriting and promoting the scholarly spirit of Chinese
renowned sociologist Fei Xiaotong is under construction in Kaixiangong Village,
Wujiang District in Suzhou City of eastChina's Jiangsu Province.
2024-09-14 20:16
6030
Gan & Lee Pharmaceuticals Presented Two Positive Clinical Results of Once-weekly Insulin GZR4 at the 60th Annual Meeting of the European Association for the Study of Diabetes (EASD 2024)
* In Phase Ia clinical study, GZR4 demonstrated favorable safety and tolerability profiles in healthy subjects, maintaining a stable glucose-lowering effect for up to one week with a single administration. * In Phase Ib clinical study, patients with Type 2 diabetes mellitus (T2DM) receiving s...
2024-09-14 19:00
4010
Maiji Mountain Grottoes: Carved in stone, evolving in time
BEIJING, Sept. 14, 2024 /PRNewswire/ -- A report from People's Daily: Southeast of Tianshui city in northwest China's Gansu province, deep in the forests in the west of the Qinling Mountains, stands the peak of the Maiji Mountain, hidden in clouds and mist. On its cliff, lifelike clay sculptures ...
2024-09-14 13:23
10392
Progress made in desertification control along Yellow River
BEIJING, Sept. 14, 2024 /PRNewswire/ -- A report from People's Daily: The Yellow River, the "mother river" of the Chinese nation, nurtures the Chinese people and fosters Chinese civilization, together with the Yangtze River. However, for a long time, due to ecosystem degradation and soil erosion...
2024-09-14 13:20
3499
Xinhua Silk Road: China's services trade fair promotes shared prosperity among global businesses
BEIJING, Sept. 14, 2024 /PRNewswire/ -- Themed "Global Services, Shared Prosperity," the 2024 China International Fair for Trade in Services (CIFTIS) opening inBeijing Thursday attracts the participation of 85 countries and international organizations, and over 450 Fortune Global 500 companies an...
2024-09-14 12:56
4182
Sinopec Wins Best Environmental Protection Case at the First Sino-European Corporate ESG Best Practice Conference in Frankfurt
FRANKFURT, Germany, Sept. 14, 2024 /PRNewswire/ -- China Petroleum & Chemical
Corporation
2024-09-14 12:23
4351
Live from ESMO 2024 | Ascentage Pharma Releases Latest Data Showing Sustained Clinical Efficacy of Olverembatinib in SDH-Deficient GIST during a Mini Oral Presentation
ROCKVILLE, Md. and SUZHOU, China, Sept. 14, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has released t...
2024-09-14 08:18
3739
Vision China: US, China urged to find right path in ties
NEW YORK, Sept. 14, 2024 /PRNewswire/ -- The article has been published by
China Daily on Sept. 13:
2024-09-14 01:10
9797
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
5310
